Marshall Wace, LLP Omeros Corp Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.48 - $5.22 $138,795 - $292,142	-55,966 Reduced 69.81%	24,206 $112,000
Q4 2022 Feb 14, 2023	SELL	$1.75 - $3.96 $73,099 - $165,413	-41,771 Reduced 34.25%	80,172 $181,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $331,881 - $801,241	-107,405 Reduced 46.83%	121,943 $385,000
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $148,897 - $487,020	77,551 Added 51.09%	229,348 $631,000
Q1 2022 May 16, 2022	BUY	$5.07 - $7.2 $769,610 - $1.09 Million	151,797 New	151,797 $912,000
Q2 2021 Aug 13, 2021	SELL	$14.81 - $19.13 $847,976 - $1.1 Million	-57,257 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$14.52 - $23.53 $161,476 - $261,677	-11,121 Reduced 16.26%	57,257 $1.02 Million
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $3.69 Million - $5.53 Million	-364,277 Reduced 84.2%	68,378 $977,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $4.14 Million - $9.22 Million	432,655 New	432,655 $4.37 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.